# UNIVERSITY OF PENNSYLVANIA: Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF PENNSYLVANIA |
| Location | PHILADELPHIA, PA |
| Project | Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer |
| Project number | 5R01CA277037-04 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $659,676 |
| Awarded | 2026-09-02 |
| Project period | 2023-09-19 to 2028-08-31 |
| UEI | GM1XX56LEP58 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11402679). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.